IndiaTickerAlivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeBSE · conference call · pdf
Source filing Company dossier
Alivus Life Sciences
NSE:ALIVUS · ISIN INE03Q201024
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Alivus Life Sciences
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Alivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome — recordingBSE · conference call recording · audio
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Alivus Life Sciences LimitedNSE · conference call · pdf
Source filing Alivus Life Sciences Ltd - 543322 - Unaudited Financial Results For The First Quarter Ended June 30, 2026.BSE · financial results · pdf
Source filing Alivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Investor PresentationBSE · investor presentation · pdf
Source filing Alivus Life Sciences Ltd - 543322 - Board Meeting Outcome for Unaudited Financial Results For The First Quarter Ended June 30, 2026BSE · financial results · pdf
Source filing Alivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSBSE · exchange filing · pdf
Source filing Alivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing Updates - Alivus Life Sciences LimitedNSE · exchange filing · pdf
Source filing Investor Presentation - Alivus Life Sciences LimitedNSE · investor presentation · pdf
Source filing Press Release - Alivus Life Sciences LimitedNSE · exchange filing · pdf
Source filing Outcome of Board Meeting - Alivus Life Sciences LimitedNSE · financial results · pdf
Archived filing Analysts/Institutional Investor Meet/Con. Call Updates - Alivus Life Sciences LimitedNSE · conference call · pdf
Source filing Alivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · conference call · pdf
Source filing Trading Window - Alivus Life Sciences LimitedNSE · exchange filing · pdf
Source filing Alivus Life Sciences Ltd - 543322 - Closure of Trading WindowBSE · financial results · pdf
Source filing Alivus Life Sciences Ltd - 543322 - Board Meeting Intimation for Considering And Approving Unaudited Financial Results Of The Company For The Quarter Ended 30Th June, 2026.BSE · financial results · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Alivus Life Sciences LimitedNSE · conference call · pdf
Source filing Alivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing Disclosure under SEBI Takeover Regulations - Alivus Life Sciences LimitedNSE · exchange filing · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Alivus Life Sciences LimitedNSE · conference call · pdf
Source filing Alivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Alivus Life Sciences LimitedNSE · conference call · pdf
Source filing Alivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing Alivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Earnings Call TranscriptBSE · conference call · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Alivus Life Sciences LimitedNSE · conference call · pdf
Source filing Alivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Alivus Life Sciences LimitedNSE · conference call · pdf
Source filing Alivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Alivus Life Sciences LimitedNSE · conference call · pdf
Source filing Alivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeBSE · conference call · pdf
Source filing Alivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome — recordingBSE · conference call recording · audio
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Alivus Life Sciences LimitedNSE · conference call · pdf
Source filing Alivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSBSE · exchange filing · pdf
Source filing Alivus Life Sciences Ltd - 543322 - Board Meeting Outcome for Audited Financial Results And Recommendation Of Final DividendBSE · financial results · pdf
Source filing Alivus Life Sciences Ltd - 543322 - Audited Financial Results For The Quarter And Year Ended March 31, 2026BSE · financial results · pdf
Source filing Alivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Investor PresentationBSE · investor presentation · pdf
Source filing Alivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing Investor Presentation - Alivus Life Sciences LimitedNSE · investor presentation · pdf
Source filing Dividend - Alivus Life Sciences LimitedNSE · exchange filing · pdf
Source filing